GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · BSE Equity Only

BSE Exchange Filings, Explained Simply

AI-powered plain-English analysis of every important BSE announcement — financial results, order wins, dividends, mergers and more. Updated live.

Today
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings

📋 Filing Types Available on ForgeUp Filings Strictly sourced from BSE exchange announcements (equity segment only). We show only material, important filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India exchange announcements. More categories will be added over time.
Lyka Labs Ltd
Update on the Scheme of Merger- Approved by NCLT Bench
M&A ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 17 Mar 2026, 04:40 PM IST  ·  BSE ID: 2a731d11-6ad5-45cf-b321-01a6193e552b
View Original BSE Filing (PDF)
💡
In Simple Terms
The court approved Lyka Labs' acquisition of Lyka Exports. Now the company must complete legal registration within 30 days.
🤖 AI Summary
  • NCLT Ahmedabad Bench approved merger of Lyka Exports into Lyka Labs on March 16, 2026
  • Lyka Labs is transferee company; Lyka Exports is transferor company under Companies Act sections 230-232
  • Appointed date for merger scheme is April 1, 2022 as per NCLT order
  • Company required to file Form INC-28 with Registrar of Companies within 30 days of order receipt
  • Follows earlier scheme announcement dated February 20, 2026; NCLT order copy enclosed and published
🔢 Key Numbers — exact figures from BSE filing, not rounded
NCLT Approval Date
March 16, 2026
Appointed Date of Merger Scheme
April 1, 2022
ROC Form Filing Deadline
Within 30 days of order receipt
NCLT Jurisdiction
Ahmedabad Bench
Legal Reference
Companies Act sections 230-232; Company Petition CP (CAA) No. 58 of 2024
🏢 How This Affects the Company
📈
Business Impact
Merger consolidates Lyka Exports' operations into Lyka Labs, integrating business units under a single entity post-appointed date.
💰
Financial Impact
Post-merger, Lyka Labs balance sheet will include Lyka Exports' assets, liabilities, and equity. Exact financial impact depends on scheme terms not detailed in this notice.
⚙️
Operational Impact
Upon scheme effectiveness, Lyka Exports ceases as separate legal entity; its employees, contracts, and assets transfer to Lyka Labs operationally.
⚠️
Risk Impact
Integration execution risk exists during 30-day ROC filing window and scheme implementation phase. Regulatory approval obtained; remaining risk is operational integration.
👥 What This Means For Shareholders
Action Required
Monitor Form INC-28 filing status with Registrar of Companies; verify scheme effectiveness announcement post-filing completion.
👤
Who Is Affected
All Lyka Labs shareholders and Lyka Exports shareholders post-merger. Scheme terms determine share conversion and equity restructuring; details not provided in this notice.
🔍
Management Signal
Management is executing pre-planned merger strategy confirmed by court approval; proceeding with regulatory filing phase demonstrates commitment to scheme completion.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Form INC-28 filing with ROC within 30 days of March 16, 2026 — verify completion by mid-April 2026
Clarification on appointed date discrepancy (April 1, 2022 vs. March 16, 2026 approval) — seek management explanation
Post-merger organization announcement — board composition, management roles, consolidated financial structure confirmation
MEDIUM RISK NCLT approval secures legal framework. Primary remaining risks: ROC filing timelines, integration execution, and appointed date anomaly resolution.
💡 Investor Takeaway
NCLT approves Lyka Labs-Lyka Exports merger on March 16, 2026. Lyka Labs absorbs Lyka Exports as transferor company. Form INC-28 filing with Registrar within 30 days triggers legal effectiveness. Appointed date anomaly (April 1, 2022) requires verification.
⚖️ Strengths & Concerns

✅ Positives

  • NCLT approval removes primary regulatory hurdle; court-approved scheme reduces legal uncertainty ahead of implementation
  • Clear timeline established: 30-day ROC filing window provides structured path to scheme effectiveness and integration completion

⚠️ Concerns

  • Appointed date listed as April 1, 2022 — significantly predates NCLT approval (March 16, 2026), creating temporal anomaly requiring clarification
  • Filing provides no financial details of merged entity, synergy estimates, or post-merger restructuring plans to assess value creation
📅 Company Track Record
Lyka Labs (BSE: 500259, NSE: LYKALABS) initiated Scheme of Amalgamation with Lyka Exports on February 20, 2026. NCLT approval on March 16, 2026 marks completion of court approval phase. No prior financial data or historical merger activity disclosed in this filing.

Based on publicly available historical data. For context only.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.